Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BostonGene and Exigent Genomic INsight (BEGIN) Study: A Prospective Study of Comprehensive Molecular Testing in Advanced Cancer Patients in the Community Setting

NCT06272864 is registered in ClinicalTrials.gov with BostonGene as lead sponsor.

NCT NCT06272864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06272864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BostonGene and Exigent Genomic INsight (BEGIN) Study: A Prospective Study of Comprehensive Molecular Testing in Advanced Cancer Patients in the Community Setting
Lead sponsor
BostonGene
Phase
Observational
Overall status
Recruiting
Start date
April 8, 2024
Completion date
January 8, 2028
Enrollment
400 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, melanoma, non-small cell lung cancer, sarcoma